Atlas Trials

Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia

Clinical trial NCT00541554 · UNKNOWN

Trial details

NCT number
NCT00541554
Sponsor
Genovate Biotechnology Co., Ltd.,
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HyperprolactinemiaWeight GainDyslipidemia
Start date
2007-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.